Novolin
- Product NDC
- 50090-6565
- 11-digit product format
- 500906565
- Labeler code
- 50090
- Product ID
- 50090-6565_4686ca34-20ab-40c8-89ca-c291d85b595d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Human Insulin
- Dosage form
- INJECTION, SUSPENSION
- Route
- SUBCUTANEOUS
- Labeler
- A-S Medication Solutions
- Application
- BLA019959
- Marketing category
- BLA
- Marketing start
- 2019-09-06
- Substance
- INSULIN HUMAN
- Active strength
- 100 [iU]/mL
- Pharmacologic classes
- Insulin [CS], Insulin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Novolin
- Brand name suffix
- N
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| INSULIN HUMAN | 100 [iU]/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 1Y17CTI5SR |
| Rxcui | 1654862, 2206099 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-6565-0 | NovolinN | 5 in 1 CARTON | INJECTION, SUSPENSION | 5 | | 1 |
| 50090-6565-0 | NovolinN | 3 mL in 1 SYRINGE, PLASTIC | INJECTION, SUSPENSION | 3 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-6565 | NOVOLIN N (HUMAN INSULIN) INJECTION, SUSPENSION [A-S MEDICATION SOLUTIONS] | 1 | Current NDC, 2 package rows | 20230722_69dffec8-6ea9-441b-b795-042dcc26843d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-6565-0 | 50090656500 | 5 SYRINGE, PLASTIC in 1 CARTON (50090-6565-0) / 3 mL in 1 SYRINGE, PLASTIC | 2023-07-18 | No | No | Historical |